¥1,526.00 ($9.67)

-39.00 (-2.49%)

Weekly Expected Move ±2.3%

¥1457 ¥1492 ¥1526 ¥1560 ¥1595

JPX · Healthcare · Medical - Distribution · Tech Score Sell · Power 34 · ¥73.4B mcap · 32M float · 0.253% daily turnover

Revenue

$600.4B +2.2% ▲

5Y CAGR: +1.3%

Gross Profit

$49.2B +1.9% ▲

5Y CAGR: +1.7%

Operating Income

$5.7B +2.7% ▲

5Y CAGR: +9.9%

Net Income

$7.3B +25.1% ▲

5Y CAGR: +9.5%

EPS (Diluted)

$149.01 +29.6% ▲

5Y CAGR: +15.8%

EBITDA

$14.6B +19.7% ▲

5Y CAGR: +5.8%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$537.1B	$577.2B	$579.8B	$587.5B	$600.4B
YoY Growth	-4.5%	+7.5%	+0.4%	+1.3%	+2.2%
Cost of Revenue	$498.8B	$533.3B	$534.8B	$539.2B	$551.2B
Gross Profit	$38.2B	$44.0B	$45.0B	$48.3B	$49.2B
Gross Margin	7.1%	7.6%	7.8%	8.2%	8.2%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$40.5B	$41.0B	$42.5B	$42.8B	$43.5B
Operating Expenses	$40.5B	$41.0B	$42.5B	$42.7B	$43.5B
Operating Income	-$2.3B	$2.9B	$4.0B	$5.6B	$5.7B
Operating Margin	-0.4%	0.5%	0.7%	0.9%	1.0%
Interest Expense	$86M	$99M	$96M	$103M	$81M
Income Before Tax	$2.4B	$7.6B	$8.1B	$8.7B	$10.7B
Tax Expense	$1.1B	$2.8B	$3.2B	$2.7B	$3.3B
Net Income	$1.2B	$4.8B	$4.8B	$5.8B	$7.3B
Net Margin	0.2%	0.8%	0.8%	1.0%	1.2%
EPS (Diluted)	$21.25	$87.88	$92.69	$115.02	$149.01
EBITDA	$5.7B	$10.9B	$11.6B	$12.2B	$14.6B
Shares Outstanding	55M	54M	52M	51M	49M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$150.8B	$163.6B	$139.7B	$148.2B	$152.1B	$164.3B	$145.9B	$154.6B
Cost of Revenue	$138.6B	$150.3B	$127.6B	$136.4B	$140.0B	$151.4B	$133.1B	$142.2B
Gross Profit	$12.2B	$13.3B	$12.1B	$11.8B	$12.1B	$12.9B	$12.8B	$12.4B
Gross Margin	8.1%	8.2%	8.6%	7.9%	7.9%	7.9%	8.8%	8.0%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$420M
SG&A Expenses	$10.6B	$10.9B	$11.8B	$10.9B	$11.2B	$11.4B	$11.9B	$11.3B
Operating Expenses	$10.6B	$10.8B	$11.8B	$10.9B	$11.2B	$11.4B	$11.9B	$11.8B
Operating Income	$1.6B	$2.5B	$301M	$807M	$835M	$1.5B	$909M	$643M
Operating Margin	1.1%	1.5%	0.2%	0.5%	0.5%	0.9%	0.6%	0.4%
Interest Expense	$22M	$18M	$19M	$17M	$15M	$22M	$14M	$18M
Income Before Tax	$2.1B	$6.0B	$1.1B	$1.3B	$6.2B	$1.6B	$2.3B	$925M
Tax Expense	$680M	$1.9B	$185M	$587M	$1.9B	$691M	$827M	$544M
Net Income	$1.4B	$4.0B	$850M	$693M	$4.3B	$921M	$1.5B	$359M
Net Margin	0.9%	2.5%	0.6%	0.5%	2.8%	0.6%	1.0%	0.2%
EPS (Diluted)	$27.85	$83.67	$17.58	$14.36	$88.48	$19.04	$30.44	$7.43
EBITDA	$3.1B	$3.3B	$2.1B	$2.3B	$7.2B	$2.5B	$2.0B	$1.7B
Shares Outstanding	49M	48M	48M	48M	48M	48M	48M	48M

3151.T JPX